Low prices for HIV drugs are only one step forward

BMJ 2004; 328 doi: 10.1136/bmj.328.7435.349-d (Published 5 February 2004)
Cite this as: BMJ 2004;328:349.5

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter A West, director (paw11@york.ac.uk)
  1. York Health Economics Consortium, University of York YO10 5NH

    EDITOR—Anything that cuts the price of drugs for HIV treatment is potentially beneficial to people with HIV infection in the developing world, as, for example, the recent deal from the World Health Organization.1 But it remains only one step on a long path.

    In many developing countries, …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL